ARCHIVES

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

This article is from The Cancer Letter archive.

Vol. 33 No. 4 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

Final Panel Meeting For Benno Schmidt; He, Upton Defend Shubik, Eppley

March 17, 1978

Adverse Events Of Chemo More Common Than Expected

August 25, 2006

New System Devised To Help Identify Emerging Comprehensive Centers

October 10, 1975

Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax.

November 9, 2001

Appropriations: NIH Professional Needs Budget Gains Attention

March 14, 1997

No More Free Cancergrams, But NCI Will Save a Bundle

October 17, 1986